日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A pharmacodynamically guided dose selection of PF-00337210 in a phase I study in patients with advanced solid tumors

在针对晚期实体瘤患者的 I 期研究中,采用药效学指导的 PF-00337210 剂量选择

Bruce, Justine Yang; LoRusso, Patricia M; Goncalves, Priscila H; Heath, Elisabeth I; Sadowski, Elizabeth; Shalinsky, David R; Zhang, Yanwei; Traynor, Anne M; Breazna, Aurora; Ricart, Alejandro D; Tortorici, Michael; Liu, Glenn

Comparison of motion correction techniques applied to functional near-infrared spectroscopy data from children

对应用于儿童功能性近红外光谱数据的运动校正技术进行比较

Hu, Xiao-Su; Arredondo, Maria M; Gomba, Megan; Confer, Nicole; DaSilva, Alexandre F; Johnson, Timothy D; Shalinsky, Mark; Kovelman, Ioulia

Words in the bilingual brain: an fNIRS brain imaging investigation of lexical processing in sign-speech bimodal bilinguals

双语大脑中的词汇:一项利用近红外光谱脑成像技术研究手语-口语双语者词汇加工的研究

Kovelman, Ioulia; Shalinsky, Mark H; Berens, Melody S; Petitto, Laura-Ann

The "Perceptual Wedge Hypothesis" as the basis for bilingual babies' phonetic processing advantage: new insights from fNIRS brain imaging

“感知楔形假说”是双语婴儿语音处理优势的基础:来自功能性近红外光谱脑成像的新见解

Petitto, L A; Berens, M S; Kovelman, I; Dubins, M H; Jasinska, K; Shalinsky, M

Dual language use in sign-speech bimodal bilinguals: fNIRS brain-imaging evidence

手语-口语双语者双语使用情况:fNIRS脑成像证据

Kovelman, Ioulia; Shalinsky, Mark H; White, Katherine S; Schmitt, Shawn N; Berens, Melody S; Paymer, Nora; Petitto, Laura-Ann

Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study

阿昔替尼对所有组织学亚型的晚期甲状腺癌均有效:一项 II 期研究的结果

Cohen, Ezra E W; Rosen, Lee S; Vokes, Everett E; Kies, Merrill S; Forastiere, Arlene A; Worden, Francis P; Kane, Madeleine A; Sherman, Eric; Kim, Sinil; Bycott, Paul; Tortorici, Michael; Shalinsky, David R; Liau, Katherine F; Cohen, Roger B

Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3

阿昔替尼 (AG-013736) 的非临床抗血管生成和抗肿瘤活性,阿昔替尼是一种口服、强效、选择性的血管内皮生长因子受体酪氨酸激酶 1、2、3 抑制剂

Dana D Hu-Lowe, Helen Y Zou, Maren L Grazzini, Max E Hallin, Grant R Wickman, Karin Amundson, Jeffrey H Chen, David A Rewolinski, Shinji Yamazaki, Ellen Y Wu, Michele A McTigue, Brion W Murray, Robert S Kania, Patrick O'Connor, David R Shalinsky, Steve L Bender

Shining new light on the brain's "bilingual signature": a functional Near Infrared Spectroscopy investigation of semantic processing

揭示大脑“双语特征”的新视角:近红外光谱功能研究语义加工

Kovelman, Ioulia; Shalinsky, Mark H; Berens, Melody S; Petitto, Laura-Ann

Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro

体外人卵巢癌细胞中顺铂和紫杉醇的协同作用

Jekunen, A P; Christen, R D; Shalinsky, D R; Howell, S B

Selective modulation of vinblastine sensitivity by 1,9-dideoxyforskolin and related diterpenes in multidrug resistant tumour cells

1,9-二脱氧福斯克林及其相关二萜类化合物对多药耐药肿瘤细胞中长春碱敏感性的选择性调节

Shalinsky, D R; Heath, D D; Jekunen, A P; Alcaraz, J E; Howell, S B